Correlation Between Handa Pharmaceuticals and Xander International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Xander International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Xander International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Handa Pharmaceuticals and Xander International, you can compare the effects of market volatilities on Handa Pharmaceuticals and Xander International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Xander International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Xander International.

Diversification Opportunities for Handa Pharmaceuticals and Xander International

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Handa and Xander is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Xander International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xander International and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Xander International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xander International has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Xander International go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and Xander International

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to generate 1.52 times more return on investment than Xander International. However, Handa Pharmaceuticals is 1.52 times more volatile than Xander International. It trades about -0.06 of its potential returns per unit of risk. Xander International is currently generating about -0.29 per unit of risk. If you would invest  6,090  in Handa Pharmaceuticals on August 27, 2024 and sell it today you would lose (270.00) from holding Handa Pharmaceuticals or give up 4.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Handa Pharmaceuticals  vs.  Xander International

 Performance 
       Timeline  
Handa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Xander International 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xander International are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Xander International may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Handa Pharmaceuticals and Xander International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Handa Pharmaceuticals and Xander International

The main advantage of trading using opposite Handa Pharmaceuticals and Xander International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Xander International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xander International will offset losses from the drop in Xander International's long position.
The idea behind Handa Pharmaceuticals and Xander International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets